Injection of copper has been used with mixed results. Present therapy consists of:
Copper acetate administered into a vein (intravenously)
Subcutaneous (injected under the skin) copper histidine
Support Groups:
Corporation for Menkes Disease -- 219-436-0137
Expectations (prognosis):
Menkes is a serious disorder, with early death being common.
Complications:
Seizures, abnormally light pigmentation of the skin and hair. Death usually occurs in the first few years of life.
Calling your health care provider:
Consult with your health care provider if you have a family history of Menkes syndrome and you plan to have children. A baby with this condition will often show symptoms early in infancy.
Review Date: 4/20/2005
Reviewed By: Neal Sondheimer, M.D., PhD., Division of Genetics and Metabolism, Children's Hospital of Philadelphia, Philadelphia, PA. Review provided by VeriMed Healthcare Network.
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 2004 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
